Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LIVN

LivaNova PLC

May 26 • 02:51PM ET

75.40

+1.57 2.13 %

Healthcare • Medical Devices • United Kingdom • Mid • NASD

May 21, 9:55 AMLivaNova names Stefano Folli President of Cardiopulmonary unit, effective June 1, 2026

Peers: ATRC INSP TFX CVRX ITGR

| Held by: IJH AVUV IWM VXF IWN MDY IJK SPMD SCHA IHI

Scroll to Statements

Index	RUT	P/E	38.92	EPS (ttm)	1.94	Insider Own	0.40%	Shs Outstand	54.90M	Perf Week	4.39%
Market Cap	4.14B	Forward P/E	16.25	EPS next Y	4.64	Insider Trans	0.00%	Shs Float	54.71M	Perf Month	17.45%
Enterprise Value	3.95B	PEG	1.74	EPS next Q	1.09	Inst Own	110.07%	Short Float	6.18%	Perf Quarter	9.20%
Income	107.13M	P/S	2.89	EPS this Y	8.88%	Inst Trans	7.62%	Short Ratio	3.87	Perf Half Y	41.15%
Sales	1.43B	P/B	3.42	EPS next Y	9.25%	ROA	4.22%	Short Interest	3.38M	Perf YTD	22.55%
Book/sh	22.06	P/C	7.67	EPS next 5Y	9.32%	ROE	9.54%	52W High	74.41 1.33%	Perf Year	80.05%
Cash/sh	9.82	P/FCF	25.72	EPS past 3/5Y	-40.20% 9.06%	ROIC	6.94%	52W Low	41.01 83.84%	Perf 3Y	71.29%
Dividend Est.	-	EV/EBITDA	14.73	Sales past 3/5Y	10.75% 8.24%	Gross Margin	67.56%	Volatility	2.83% 3.88%	Perf 5Y	-8.38%
Dividend TTM	-	EV/Sales	2.75	EPS Y/Y TTM	148.08%	Oper. Margin	14.46%	ATR (14)	2.64	Perf 10Y	54.51%
Dividend Ex-Date	-	Quick Ratio	1.11	Sales Y/Y TTM	12.40%	Profit Margin	7.47%	RSI (14)	67.80	Recom	1.75
Dividend Gr. 3/5Y	- -	Current Ratio	1.33	EPS Q/Q	106.63%	SMA20	10.51%	Beta	0.86	Target Price	81.50
Payout	-	Debt/Eq	0.28	Sales Q/Q	14.33%	SMA50	15.02%	Rel Volume	0.25	Prev Close	73.83
Employees	3300	LT Debt/Eq	0.27	Earnings	May 06 BMO	SMA200	24.20%	Avg Volume	874.30K	Price	75.40
IPO	Feb 11, 1993	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.30% 4.69%	Trades		Volume	184,488	Change	2.13%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-19-25	Initiated	KeyBanc Capital Markets	Overweight	$81
Oct-01-25	Downgrade	Goldman	Buy → Neutral	$55
May-20-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$60
Feb-26-25	Downgrade	Wolfe Research	Outperform → Peer Perform
Oct-04-24	Initiated	Goldman	Buy	$65
Sep-17-24	Upgrade	Robert W. Baird	Neutral → Outperform	$55 → $66
Mar-20-24	Reiterated	Needham	Buy
Feb-20-24	Upgrade	Mizuho	Neutral → Buy	$60 → $70
Sep-06-23	Initiated	HSBC Securities	Hold	$52
Jul-19-23	Initiated	Robert W. Baird	Neutral	$56
Apr-14-23	Initiated	Mizuho	Neutral	$48
Dec-21-22	Initiated	Barclays	Equal Weight	$62
Apr-06-22	Initiated	Wolfe Research	Outperform	$95
Feb-24-22	Upgrade	UBS	Neutral → Buy	$96
Dec-03-21	Initiated	Goldman	Buy	$108
Aug-20-21	Reiterated	Needham	Buy	$104 → $117
Jul-20-21	Upgrade	Needham	Hold → Buy	$93
Mar-03-21	Downgrade	Berenberg	Buy → Hold	$84
Jan-05-21	Downgrade	Needham	Buy → Hold
Sep-02-20	Initiated	Robert W. Baird	Outperform	$55

Show Previous Ratings

May-21-26 09:15AM	LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit (Business Wire)
May-19-26 08:00AM	LivaNova to Present at Goldman Sachs Global Healthcare Conference in June (Business Wire)
May-06-26 04:52PM	LivaNova PLC Q1 2026 Earnings Call Summary (Moby) +15.05% +7.04%
08:32AM	LivaNova (LIVN) beats quarterly expectations but shares slip on cautious guidance reaction (InvestorsHub)
06:11AM	LivaNova: Q1 Earnings Snapshot (Associated Press)
06:00AM	Loading…
06:00AM	LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance (Business Wire)
Apr-20-26 05:05PM	Annals of Internal Medicine Publishes 12-Month Results from LivaNova's OSPREY Clinical Study for Obstructive Sleep Apnea (Business Wire)
Mar-27-26 10:15AM	MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value (PR Newswire)
Mar-25-26 09:00AM	LivaNova to Announce First-Quarter 2026 Results (Business Wire)
Mar-19-26 08:30AM	LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea (Business Wire)
Mar-10-26 11:40AM	Key Catalysts That Will Likely Drive Prospects for NPCE Stock in 2026 (Zacks)
11:39AM	NPCE RNS System Explained: Growth Drivers and Setup for 2026 (Zacks)
11:21AM	NeuroPace's Seizure ID and New Indication Could Expand RNS Demand (Zacks)
Mar-05-26 12:00PM	All You Need to Know About LivaNova (LIVN) Rating Upgrade to Buy (Zacks)
Feb-25-26 03:29PM	LivaNova Q4 Earnings Call Highlights (MarketBeat)
02:28PM	Loading…
02:28PM	Analyst Report: LivaNova PLC (Morningstar Research)
02:01PM	LivaNova PLC (LIVN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
12:36PM	LivaNova PLC Q4 2025 Earnings Call Summary (Moby)
12:30PM	LivaNova (LIVN) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
12:15PM	LivaNova (LIVN) Tops Q4 Earnings and Revenue Estimates (Zacks)
06:07AM	LivaNova: Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	LivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance (Business Wire)
Feb-24-26 07:30PM	Inogen (INGN) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Feb-02-26 02:51PM	Three Global Leaders Near Buy Points With Earnings Ahead (Investor's Business Daily)
Jan-30-26 02:31PM	LivaNova (LIVN) Upgraded to Overweight by KeyBanc (Insider Monkey)
Jan-29-26 09:03AM	Royal Caribbean Guidance Lifts Cruise Stocks. RCL, VIK Shares Jump. (Investor's Business Daily)
08:21AM	Stock Market Today: Dow Edges Higher As Microsoft Dives On Earnings; Meta, Tesla Rally (Live Coverage) (Investor's Business Daily)
08:03AM	Lockheed Martin Stock Is Breakout-Ready On Q4 Results, THAAD Deal (Investor's Business Daily)
Jan-28-26 05:10PM	Dow Jones Futures: Tesla, Meta, Microsoft Lead Big Earnings Movers After Market Pause (Investor's Business Daily)
01:46PM	IBD Stock Of The Day, LivaNova, Forms A Unique Base; Will New Opportunities Drive It Higher? (Investor's Business Daily)
09:00AM	Loading…
Jan-20-26 09:00AM	LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results (Business Wire)
Dec-23-25 09:00AM	LivaNova to Present at J.P. Morgan Healthcare Conference in January (Business Wire)
Dec-03-25 09:00AM	LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting (Business Wire)
Dec-02-25 09:00AM	LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea (Business Wire)
Nov-25-25 09:00AM	LivaNova to Present at Piper Sandler Healthcare Conference in December (Business Wire)
Nov-24-25 07:21PM	Analyst Report: LivaNova PLC (Morningstar Research) +9.35%
09:00AM	LivaNova's VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services (Business Wire)
Nov-13-25 07:40PM	Analyst Report: LivaNova PLC (Morningstar Research)
Nov-12-25 03:26PM	LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day (Business Wire) +7.48%
Nov-06-25 10:00PM	LivaNova PLC (LIVN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Pressures (GuruFocus.com)
Nov-05-25 07:10AM	LivaNova (LIVN) Tops Q3 Earnings and Revenue Estimates (Zacks) -5.80%
06:13AM	LivaNova: Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance (Business Wire)
Oct-31-25 09:40AM	Is LivaNova (LIVN) Stock Undervalued Right Now? (Zacks)
Oct-23-25 09:00AM	LivaNova to Present at Wolfe Research Healthcare Conference in November (Business Wire)
Oct-08-25 09:00AM	LivaNova to Announce Third-Quarter 2025 Results (Business Wire)
Oct-07-25 09:00AM	LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting (Business Wire)
Oct-02-25 09:10AM	Nyxoah Expands in the Middle East to Provide Wider Access to Genio (Zacks)
Oct-01-25 09:44AM	Apple initiated, DraftKings downgraded: Wall Street's top analyst calls (The Fly)
Sep-30-25 09:40AM	Should Value Investors Buy LivaNova (LIVN) Stock? (Zacks)
Sep-08-25 04:34PM	LivaNova PLC (LIVN) Soars to 52-Week High, Time to Cash Out? (Zacks)
Sep-04-25 09:00AM	LivaNova Appoints Donald Zurbay as a New Director (Business Wire)
Aug-22-25 09:00AM	LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September (Business Wire) +5.75%
Aug-18-25 09:00AM	LivaNova Launches Essenz Perfusion System in China (Business Wire)
Aug-15-25 10:10AM	Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea (Zacks)
Aug-06-25 07:35PM	Analyst Report: LivaNova PLC (Morningstar Research) +11.15%
07:10AM	LivaNova (LIVN) Q2 Earnings and Revenues Beat Estimates (Zacks)
06:11AM	LivaNova: Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	LivaNova Reports Second-Quarter 2025 Results; Raises 2025 Guidance (Business Wire)
Aug-05-25 07:45AM	Avanos Medical (AVNS) Misses Q2 Earnings Estimates (Zacks)
Aug-04-25 10:02AM	Jefferies Maintained a Buy Rating on LivaNova PLC (LIVN) (Insider Monkey)
Jul-30-25 11:49AM	Jefferies Reaffirms 'Buy' Rating on LivaNova PLC (LIVN) with $79 PT (Insider Monkey)
Jul-29-25 04:38AM	Europe Defibrillator Market Forecast and Company Analysis Report 2025-2033 Featuring Medtronic, Philips, Nihon Kohden, Boston Scientific, Stryker, Asahi Kasei, LivaNova, and Abbott (GlobeNewswire)
Jul-16-25 09:39AM	Jefferies Reiterates a Buy Rating on LivaNova PLC (LIVN) With a $79 PT (Insider Monkey)
Jul-11-25 08:12PM	Analyst Report: LivaNova PLC (Morningstar Research) -5.01%
Jul-09-25 09:00AM	LivaNova to Announce Second-Quarter 2025 Results (Business Wire)
Jun-25-25 11:37AM	Are Options Traders Betting on a Big Move in LivaNova Stock? (Zacks)
Jun-10-25 08:33PM	Analyst Report: LivaNova PLC (Morningstar Research)
Jun-06-25 09:58AM	LivaNova completes epilepsy treatment study of VNS Therapy (Medical Device Network)
Jun-05-25 08:15AM	CORE-VNS Study Further Validates Effectiveness of LivaNovas VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy (Business Wire)
08:00AM	LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy (Business Wire)
Jun-04-25 08:00AM	LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression (Business Wire)
May-15-25 08:00AM	LivaNova to Present at the Jefferies Global Healthcare Conference (Business Wire)
May-08-25 03:10AM	LivaNova PLC (LIVN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances (GuruFocus.com)
May-07-25 11:31AM	Analyst Report: LivaNova PLC (Morningstar Research) +23.72%
07:15AM	LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates (Zacks)
06:14AM	LivaNova: Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance (Business Wire)
05:45AM	LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy (Business Wire)
May-06-25 06:05PM	Masimo (MASI) Q1 Earnings and Revenues Surpass Estimates (Zacks)
May-01-25 05:15PM	DexCom (DXCM) Q1 Earnings Miss Estimates (Zacks)
Apr-25-25 04:30PM	Is LivaNova PLC (LIVN) the Best Undervalued UK Stock to Buy Right Now? (Insider Monkey)
Apr-14-25 09:51AM	LivaNova PLC (LIVN): Among the Best UK Stocks to Buy According to Billionaires (Insider Monkey)
Apr-10-25 04:32AM	LivaNova PLC: Excellent Revenue Earner, Some Short-Term Litigation Concerns (Seeking Alpha)
Mar-26-25 08:00AM	LivaNova to Announce First-Quarter 2025 Results (Business Wire)
Mar-04-25 11:56PM	Is LivaNova PLC (LIVN) the Best Medical Technology Stock to Buy According to Analysts? (Insider Monkey)
10:12PM	Analyst Report: LivaNova PLC (Morningstar Research)
Feb-26-25 02:04AM	LivaNova PLC (LIVN) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ... (GuruFocus.com)
Feb-25-25 08:32PM	Analyst Report: LivaNova PLC (Morningstar Research) -15.76%
07:10AM	LivaNova (LIVN) Tops Q4 Earnings Estimates (Zacks)
06:10AM	LivaNova: Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	LivaNova Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Guidance (Business Wire)
Feb-21-25 12:39PM	Getinges surgical perfusion market exit opens door for LivaNova (Medical Device Network)
09:00AM	LivaNova to Present at the Barclays Global Healthcare Conference (Business Wire)
Feb-13-25 05:32AM	Getinge plans to leave surgical perfusion (Medical Device Network)
Jan-23-25 10:25AM	Should You Sell LivaNova PLC (LIVN)? (Insider Monkey)
Jan-21-25 09:00AM	LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results (Business Wire)
Jan-14-25 11:18AM	Analyst Report: LivaNova PLC (Morningstar Research)
Jan-06-25 09:00AM	LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer (Business Wire)
Dec-18-24 08:30AM	RECOVER Clinical Study Shows Meaningful Benefits of LivaNovas VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression (Business Wire)

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.

CEO & DirectorMr. Vladimir A. Makatsaria

Chief Financial OfficerMr. Alex Shvartsburg C.M.A.

Chief Human Resources OfficerMs. Natalia Kozmina

Chief Innovation OfficerMr. Ahmet Tezel Ph.D.

VP & Chief Accounting OfficerMs. Lindsey Little

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Tezel Ahmet	Chief Innovation Officer	Mar 30 '26	Option Exercise	0.00	3,408	0	5,343	Apr 01 05:20 PM
Poletti Franco	President, Cardiopulmonary	Mar 30 '26	Option Exercise	0.00	3,184	0	12,125	Apr 01 05:20 PM
Shvartsburg Alex	Chief Financial Officer	Mar 30 '26	Option Exercise	0.00	30,835	0	57,515	Apr 01 05:20 PM
Makatsaria Vladimir	Chief Executive Officer	Mar 30 '26	Option Exercise	0.00	21,042	0	25,326	Apr 01 05:20 PM
Bolton Stephanie	President, Global Epilepsy	Mar 30 '26	Option Exercise	0.00	17,815	0	30,566	Apr 01 05:20 PM
Kozmina Natalia	Chief Human Resources Officer	Mar 30 '26	Option Exercise	0.00	6,389	0	6,389	Apr 01 05:20 PM
Poletti Franco	President, Cardiopulmonary	Mar 11 '26	Option Exercise	57.60	2,140	123,264	10,990	Mar 13 05:25 PM
Poletti Franco	President, Cardiopulmonary	Dec 15 '25	Option Exercise	0.00	967	0	9,266	Dec 17 04:06 PM
PODLOGAR SUSAN M	Director	Dec 15 '25	Option Exercise	0.00	2,355	0	2,355	Dec 17 04:06 PM
Hutchinson Michael Damon	SVP, CLO and Company Secretary	Dec 15 '25	Option Exercise	0.00	2,254	0	7,920	Dec 17 04:06 PM
Story Brooke	Director	Nov 18 '25	Sale	53.94	250	13,485	6,232	Nov 19 03:57 PM
Story Brooke	Director	Nov 18 '25	Proposed Sale	53.94	250	13,485		Nov 18 04:51 PM
Poletti Franco	President, Cardiopulmonary	Sep 15 '25	Option Exercise	0.00	643	0	8,576	Sep 17 04:05 PM
Bianchi Francesco	Director	Aug 25 '25	Sale	56.50	1,500	84,750	9,028	Aug 27 04:17 PM
Bianchi Francesco	Director	Aug 25 '25	Proposed Sale	56.50	1,500	84,750		Aug 25 04:26 PM
O'Kane Sharon	Director	Jun 15 '25	Option Exercise	0.00	3,416	0	12,910	Jun 17 04:55 PM
Bianchi Francesco	Director	Jun 15 '25	Option Exercise	0.00	3,416	0	10,938	Jun 17 04:54 PM
SCHERMERHORN TODD C	Director	Jun 15 '25	Option Exercise	0.00	3,416	0	9,473	Jun 17 04:54 PM
KOZY WILLIAM A	Director	Jun 15 '25	Option Exercise	0.00	4,840	0	33,148	Jun 17 04:54 PM
Barry James Christopher	Director	Jun 15 '25	Option Exercise	0.00	3,416	0	4,772	Jun 17 04:54 PM
Story Brooke	Director	Jun 15 '25	Option Exercise	0.00	3,416	0	6,892	Jun 17 04:54 PM
Enxing Seng Stacy	Director	Jun 15 '25	Option Exercise	0.00	3,416	0	12,161	Jun 17 04:54 PM
WILVER PETER M	Director	Jun 15 '25	Option Exercise	0.00	3,416	0	7,148	Jun 17 04:54 PM
Tezel Ahmet	Chief Innovation Officer	Jun 15 '25	Option Exercise	0.00	2,967	0	2,967	Jun 17 04:53 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LIVN

LivaNova PLC

Upgrade your Finviz experience